What is DRRX's gross margin?

DURECT (DRRX) has a gross margin of 98% and a net margin of -507%.

What is DRRX's P/E ratio?

Track DURECT (DRRX) P/E ratio, ROE, and valuation metrics over time.

Where can I see DRRX's full financials?

See DURECT (DRRX) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

DURECT (DRRX) Financials — Revenue, Earnings, Cash Flow

$1.91

Last traded 2025-09-11 — delisted

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $59.3M mcap · 26M float · 4.51% daily turnover · Short 45% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$3M

Revenue

-62.6% YoY

$-3M

Net Income

+78.0% YoY

$-14M

Free Cash Flow

+44.6% YoY

98.4%

Gross Margin

-627.1%

Op. Margin

-506.7%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-77.5%

ROA-16.4%

ROIC1622.0%

Valuation

P/E-7.1

P/B6.5

EV/EBITDA-1.0

Leverage

Debt/Equity0.44

Current Ratio0.98

Interest Cov.-41.1x

Quality Scores

Piotroski F4/9

Altman Z-70.05

Beneish M1.18